GDP-Fucose—Mastering glycosylation and empowering the “precision definer” of next-generation biopharmaceuticals

Guanosine diphosphate-5'-fucose disodium salt (GDP-Fucose) is a key active donor molecule in the cellular glycosylation pathway and is known as the "gold currency of fucosylation". It is not only an important metabolic intermediate in life, but also a core raw material for precise functional regulation in the fields of cutting-edge biomedicine, especially antibody drugs, protein drugs and cell therapy.

Chemical Information

Chemical name: 5'-Guanosine diphosphate-fucose disodium salt

Common name: GDP-fucose, GDP-L-fucose disodium salt

Chemical formula: C16H25N5O15P2

Molecular weight: 589.34 g/mol

CAS number: 15839-70-0

Structural features

GDP-fucose is composed of a guanine nucleotide (GMP) linked to an L-fucose molecule through a pyrophosphate bond. Its unique features are:

High-energy donor role: As the sole substrate of fucosyltransferases (FUTs), fucose is precisely transferred to specific sites on sugar chains, proteins or lipids through enzymatic reactions.

Structure determines function: L-fucose is a key six-carbon deoxysaccharide. Its introduction can significantly change the surface properties and spatial structure of biological macromolecules, thereby directly affecting its biological activity and stability.

Main applications and advantages

1. Key raw materials for optimization of glycoproteins and antibody drugs

Enhance antibody effector function: Through in vitro fucosylation transformation, removing the fucose in the Fc segment of the antibody (i.e. producing a "defucosylated" antibody) can significantly enhance its antibody-dependent cell-mediated cytotoxicity (ADCC), thus greatly improving the efficacy of therapeutic antibodies (such as anti-cancer antibodies).

Improve pharmacokinetics: Precise glycosylation modification helps optimize the stability, half-life and immunogenicity of therapeutic protein drugs, and is one of the core technologies for the development of "Best-in-Class" biopharmaceuticals.

2. The driving force behind cell therapy and diagnosis

Regulates cell recognition and adhesion: Fucosylation is crucial in the formation of cell surface markers (such as selectin ligands), directly affecting processes such as immune cell homing, inflammatory response, and tumor metastasis.

Stem cell and immunotherapy research: Cell surface sugar profile, especially fucose modification, is a key regulator of stem cell pluripotency, differentiation and immune cell function. Using high-purity GDP-fucose, the glycosylation status of cells can be precisely controlled in vitro to empower cell therapy products.

3. Core tools for enzymology and basic research

Fucosyltransferase (FUT) activity assay: As a natural substrate of FUT enzyme, it is an essential reagent for enzyme kinetic studies, high-throughput screening and inhibitor discovery.

Chemoenzymatic synthesis: In synthetic biology, using FUT enzymes and GDP-fucose, sugar chains or glycoconjugates with well-defined structures can be synthesized efficiently and specifically for drug development and diagnostic reagent development.

Conclusion

5'-Guanosine diphosphate-fucose disodium salt is not just a metabolic molecule, it is the key to accurately decoding and reshaping the "sugar language" of life. From enhancing the lethality of antibody drugs to finely regulating the efficacy of cell therapy, its potential is being rapidly tapped.